Bristol-Myers Squibb BMY EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from Bristol-Myers Squibb’s reported figures.
Based on the most recent quarter.
The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bristol-Myers Squibb's ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bristol-Myers Squibb's EV / EBITDA?
- Bristol-Myers Squibb (BMY) reported EV / EBITDA of 12× in Q1 2026.
- How has Bristol-Myers Squibb's EV / EBITDA changed year-over-year?
- Bristol-Myers Squibb's EV / EBITDA increased by 3.5% year-over-year, from 11.6× to 12×.
- What is the long-term trend for Bristol-Myers Squibb's EV / EBITDA?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's EV / EBITDA has grown at a -16.7% compound annual growth rate (CAGR), from 88.5× to 42.7×.
- What does EV / EBITDA mean?
- What the whole business (debt included) costs relative to its operating cash earnings.
- How do you interpret EV / EBITDA?
- Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
- How does EV / EBITDA compare across companies?
- Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.